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Evidence implicates environmental factors in the pathogenesis of Autism Spectrum Disorders (ASD). However,
the identity of speciﬁc environmental chemicals that inﬂuence ASD risk, severity or treatment outcome remains
elusive. The impact of any given environmental exposure likely varies across a population according to individual
genetic substrates, and this increases the difﬁculty of identifying clear associations between exposure and ASD
diagnoses. Heritable genetic vulnerabilities may amplify adverse effects triggered by environmental exposures
if genetic and environmental factors converge to dysregulate the same signaling systems at critical times of de-
velopment. Thus, one strategy for identifying environmental risk factors for ASD is to screen for environmental
factors that modulate the same signaling pathways as ASD susceptibility genes. Recent advances in deﬁning
the molecular and cellular pathology of ASD point to altered patterns of neuronal connectivity in the developing
brain as the neurobiological basis of these disorders. Studies of syndromic ASD and rare highly pene-
trant mutations or CNVs in ASD suggest that ASD risk genes converge on several major signaling path-
ways linked to altered neuronal connectivity in the developing brain. This review brieﬂy summarizes
the evidence implicating dysfunctional signaling via Ca2+-dependent mechanisms, extracellular
signal-regulated kinases (ERK)/phosphatidylinositol-3-kinases (PI3K) and neuroligin–neurexin–
SHANK as convergent molecular mechanisms in ASD, and then discusses examples of environmental
chemicals for which there is emerging evidence of their potential to interfere with normal neuronal
connectivity via perturbation of these signaling pathways.
© 2012 Elsevier Inc. All rights reserved.
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1. Introduction
Autism Spectrum Disorders (ASD) is a group of neurodevelop-
mental disorders deﬁned by core deﬁcits in social reciprocity and
communication, restrictive interests and repetitive behaviors. The
severity of core symptoms and co-morbidities (mental retardation,
seizures, gastrointestinal symptoms) as well as the response to treat-
ment varies considerably, and this clinical heterogeneity is a hallmark
characteristic of these disorders (Geschwind, 2009; Geschwind and
Levitt, 2007; Nazeer and Ghaziuddin, 2012). ASD continues to in-
crease at an alarming rate with the most recent statistics released
by the Centers for Disease Control (CDC) indicating an incidence of
1.14%, or one in every 88 neurotypical children (CDC, 2008). Consid-
ering the sex-bias of ASD, which has a male to female ratio of approx-
imately 4:1, this translates into an even higher incidence (1 in 54) for
boys (Baron-Cohen et al., 2011). Recent ﬁndings from a study of more
than 6 million ASD patients indicate that the prevalence of ASD seems
to be increasing linearly from year to year (Keyes et al., 2012). While
increased awareness, improved detection and broadening of diagnos-
tic criteria for ASD contribute to the progressive rise in ASD incidence,
several studies indicate that there is indeed a true increase in the fre-
quency of this disorder, with factors other than diagnostic drift likely
accounting for more than half of new cases (Grether et al., 2009;
Hertz-Picciotto and Delwiche, 2009; King and Bearman, 2009).
While ASD is considered to be one of the most heritable com-
plex neurodevelopmental disorders (El-Fishawy and State, 2010;
Geschwind, 2011), genes linked to ASD rarely segregate in a simple
Mendelian manner (El-Fishawy and State, 2010). Thus, it has been
widely posited that multiple genetic etiologies, including rare, private
(de novo) single gene mutations that are highly penetrant, interac-
tions between inherited, common functional variants of multiple
genes with small to moderate effects on ASD, or copy number varia-
tion (CNV), occur independently or in combination to determine
ASD risk (Abrahams and Geschwind, 2008; Judson et al., 2011; Levitt
and Campbell, 2009; O'Roak and State, 2008; Veenstra-Vanderweele
et al., 2004). An alternative but not mutually exclusive hypothesis is
that environmental factors interact with genetic susceptibilities to
inﬂuence ASD risk, clinical phenotype and/or treatment outcome
(Herbert, 2010; Pessah and Lein, 2008). Early indications of an envi-
ronmental contribution to ASD came from observations of a high inci-
dence of autism associated with in utero exposure to valproic acid
(Rodier et al., 1997) or congenital rubella (Chess et al., 1978). Howev-
er, consistent ﬁndings from twin studies of incomplete monozygotic
concordance (Herbert, 2010) together with the observation that
even in genetic syndromes highly associated with ASD, a signiﬁcant
percentage of carriers do not express autistic phenotypes (Levitt and
Campbell, 2009), suggest that environmental risk factors for ASD are
not limited to thesewell-deﬁned in utero exposures. In one of the larg-
est twin studies conducted to date, 192 mono- and dizygotic twin
pairs were analyzed to quantify the relative contributions of genetic
heritability versus the shared environment. The ﬁndings from these
analyses suggested that 38% of ASD cases are attributable to genetic
causes whereas 58% are linked to the shared in utero environment
(Hallmayer et al., 2011). While the model used in this study had a
number of inherent biases (e.g., it was assumed there were no
gene×environment interactions, monozygotic and dizygotic twins
were assumed to share the environment to the same extent, and
there are questions regarding the validity of the values used for the
prevalence for autism and ASD), and these ﬁndings have yet to be
replicated in an independent study of a different cohort of children,
the conclusion from this study that environmental modiﬁers contrib-
ute to ASD risk is certainly consistent with the clinical heterogeneity
of ASD. A signiﬁcant contribution from environmental factors would
also provide a plausible explanation for the rapid increase in the
incidence of ASD over the past few decades (Hertz-Picciotto and
Delwiche, 2009).
How environmental factors might interact with genetic suscepti-
bilities to increase ASD risk remains largely unknown. Answering
this question is complicated by the fact that efforts to identify speciﬁc
environmental risk factors for ASD have produced a number of candi-
dates but few deﬁnitive hits (DeSoto, 2009; Herbert, 2010; Kalia,
2008; Landrigan, 2010; Landrigan et al., 2012; Pessah and Lein,
2008; Shelton et al., 2012). If the complexity of heritable factors con-
tributing to autism susceptibility creates a range of sensitivities of the
developing brain to the adverse effects of environmental factors
(Herbert, 2010; Levitt and Campbell, 2009; Pessah and Lein, 2008),
then establishing clear associations between exposure to environ-
mental factors and ASD diagnosis will be challenging. This argues
for the critical need to employ “reverse epidemiology” in which ex-
perimental models are used to identify relevant gene × environment
interactions and this information is then used to inform and focus
subsequent epidemiological studies. We propose that one approach
for applying this strategy is to identify environmental factors that
modulate the same signaling pathways as ASD susceptibility genes
to cause adverse neurodevelopmental outcomes of relevance to ASD
(Pessah and Lein, 2008). The rationale behind this approach is that
genetic susceptibilities may amplify the adverse effects of environ-
mental exposures if both factors (genes and environment) converge
at critical times during neurodevelopment to interfere with the
same signaling pathway.
The feasibility of this experimental approach is strengthened by re-
cent advances in deﬁning themolecular and cellular pathology of ASD.
Genetic, histological, electrophysiological and functional imaging
studies of children and adults with ASD all point to altered patterns
of neuronal connectivity in the developing brain as the neuro-
biological substrate underlying these disorders (Bourgeron, 2009;
Geschwind and Levitt, 2007; Judson et al., 2011; Zoghbi and Bear,
2012). Importantly, there is increasing evidence from both human ge-
netics and experimental models that many ASD risk genes converge
on several major signaling pathways that play key roles in regulating
neuronal connectivity in the developing brain (Bourgeron, 2009;
Krey and Dolmetsch, 2007; Levitt and Campbell, 2009; Pardo and
Eberhart, 2007; Zoghbi and Bear, 2012). This review will present a
brief summary of the evidence implicating dysfunctional Ca2+-
dependent signaling (Krey and Dolmetsch, 2007; Pessah and Lein,
2008), signaling through extracellular signal-regulated kinases
(ERK) and phosphatidylinositol-3-kinases (PI3K) (Bourgeron, 2009;
Judson et al., 2011; Levitt and Campbell, 2009), and neuroligin–
neurexin–SH3 and multiple ankyrin repeat domain (SHANK) interac-
tions (Bourgeron, 2009; Sudhof, 2008) in ASD followed by examples of
environmental chemicals for which there is emerging evidence of
their potential to interfere with normal neuronal connectivity via per-
turbation of these signaling pathways.
2. Neuronal connectivity as a convergent target in ASD
While the pathogenesis of ASD has yet to be determined, it is clear
that altered neuronal connectivity is involved. Functional magnetic
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resonance imaging (fMRI) studies have demonstrated altered pat-
terns of cortical activation in diagnosed children and adults with
ASD during the performance of social and cognitive tasks, as well as
abnormal intrinsic functional connectivity (anterior–posterior and/
or interhemispheric connections) [reviewed in Judson et al., 2011;
Rudie et al., 2012]. These functional deﬁcits include reduced
long-range functional connectivity in the cortex and enhanced local
connectivity in multiple brain regions [reviewed in Amaral et al.,
2008; Geschwind and Levitt, 2007; Judson et al., 2011]. Diffusion
tensor imaging studies (DTI) demonstrate abnormalities in anteri-
or–posterior and interhemispheric white matter tracts [reviewed in
Judson et al., 2011; Rudie et al. 2012]. In some cases of ASD, aberrant
functional connectivities are postulated to reﬂect an increased ratio of
excitation to inhibition in sensory, mnemonic, social and emotional
systems (Rubenstein and Merzenich, 2003). This hypothesis is
derived from clinical studies indicating an imbalance of excitatory
to inhibitory neurotransmission in brain regions of relevance to ASD
(DeVito et al., 2007; Lewine et al., 1999; Page et al., 2006; Wheless
et al., 2002), as well as recent research indicating dysfunctional
GABAA receptors in ASD patients (Mendez et al., in press).
Postmortem studies of brain tissue from ASD subjects provide ev-
idence of perturbed neuronal connectivity at the structural level.
Brain tissue from adult ASD subjects exhibits ultrastructural charac-
teristics suggestive of local hyperconnectivity and distal under-
connectivity in prefrontal regions involved in attention, emotion
and executive function. This involves changes in the proportion of
small, medium, large and extra-large diameter axons between the
anterior cingulate cortex, the orbitofrontal cortex and the lateral
prefrontal cortex in ASD subjects compared to matched controls,
and reduced myelin thickness in axons below the orbitofrontal cortex
(Zikopoulos and Barbas, 2010). Increased spine density in Golgi-
impregnated pyramidal neurons of layer II in the frontal, temporal
and parietal lobes and layer V of the temporal lobe in ASD patients
suggests skewed cortical synaptic activity towards excitation, al-
though functional evidence of excitation is needed to further support
this hypothesis (Hutsler and Zhang, 2010). Abnormal spine morphol-
ogy is also found in the temporal and visual cortices of subjects with
Fragile-X, a syndrome with high incidence of ASD (Irwin et al., 2001).
Collectively, histological evidence combined with ﬁndings from imag-
ing studies strongly indicate impaired neuronal network connectivity
as the basis of behavioral and cognitive abnormalities in ASD.
The heterogeneous clinical phenotypes that are characteristic of
ASD (Geschwind, 2009; Geschwind and Levitt, 2007; Nazeer and
Ghaziuddin, 2012) presumably reﬂect differences in when, how and
which brain circuits are affected (Judson et al., 2011).
A number of neurodevelopmental processes ranging from early
events of cell proliferation and differentiation to migration and axo-
nal outgrowth to late events involving maturation of the dendritic
arbor, synaptogenesis and myelination are critical to setting up
mature patterns of neuronal connectivity in all regions of the brain,
including those of relevance to ASD. Perturbations of the spatiotem-
poral patterns or magnitude of any of these events could theoretically
interfere with the formation of meaningful networks and give rise to
the deﬁcits in functional connectivity associated with ASD (Belmonte
and Bourgeron, 2006; Lein et al., 2005). Insight as to which of these
neurodevelopmental processes may be preferentially targeted in
ASD comes from genetic studies of ASD and neuropathological evi-
dence from syndromic disorders with a high incidence of ASD diag-
nosis, including Angelman syndrome, Fragile X syndrome, Rett
syndrome, Smith Lemli–Opitz syndrome, Timothy syndrome, neuroﬁ-
bromatosis and tuberous sclerosis. Data from these studies suggest
that the late stages of neurodevelopment, e.g., dendritic growth,
synaptogenesis and myelination, are probably most vulnerable
[reviewed in Levitt and Campbell, 2009]. This is consistent with the
fact that ASD is typically diagnosed within the ﬁrst three years of
life, a period characterized by extensive formation and reﬁnement
of synaptic connections in the human brain (Huttenlocher and
Dabholkar, 1997). Research ﬁndings from studies of transgenic
animal models expressing ASD-associated genes further support the
hypothesis that the changes in synaptic connectivity observed in chil-
dren at risk for ASD arise from perturbations of dendritic growth, syn-
apse formation and synapse stabilization (Bourgeron, 2009; Zoghbi
and Bear, 2012). It is these critical later neurodevelopmental events
that will be the focus of this review.
Data emerging from studies of syndromic ASD and rare highly
penetrant mutations or CNVs in ASD have identiﬁed distinct adhesion
proteins needed to maintain and modify synapses in response to ex-
perience, aswell as intracellular signaling pathways that control dendritic
arborization and/or synaptogenesis signaling systems that appear to
represent convergentmolecularmechanisms in ASD. The former includes
neuroligins, neurexins, contactin-associated protein-2 (CNTNAP2) and
SHANK proteins (Abrahams and Geschwind, 2008; Bourgeron, 2009;
O'Roak andState, 2008; Sudhof, 2008); the latter, Ca2+-dependent signal-
ing (Krey and Dolmetsch, 2007), as well as ERK and PI3K signaling (Levitt
and Campbell, 2009).
2.1. Synaptic proteins in ASD
Rare mutations in genes that encode synaptic proteins, speciﬁcally
neuroligins 3 and 4 (NLGN3, NLGN4), neurexins 1 and 3 (NRXN1,
NRXN3), CNTNAP2 (CNTNAP2) and Shank3 (SHANK3), are overrepre-
sented in ASD compared to neurotypical children (Alarcon et al.,
2008; Arking et al., 2008; Bakkaloglu et al., 2008; Durand et al., 2007;
Jamain et al., 2003; Kim et al., 2008; Laumonnier et al., 2004; Szatmari
et al., 2007; Yan et al., 2005). Neuroligins are expressed in postsynaptic
membranes and function as cell adhesion molecules, bridging the
synaptic cleft by binding to neurexins expressed on the opposing pre-
synaptic membrane (Sudhof, 2008). CNTNAP2 is a synaptic protein
that is homologous to neurexin, and SHANK3 is a scaffolding protein
in the postsynaptic density that functions downstream of neuroligin–
neurexin binding (Bourgeron, 2009). Neuroligin–neurexin–SHANK in-
teractions regulate activity-dependent synaptogenesis and synapse
maintenance in the developing brain (Craig and Kang, 2007; Scheiffele
et al., 2000). There are ﬁve known isoforms of neuroligin, each encoded
by a separate gene. These isoforms differentially regulate the formation
of excitatory and inhibitory synapses in vitro (Craig and Kang, 2007;
Scheiffele et al., 2000). In particular, neuroligin-2 enhances the forma-
tion of GABAergic inhibitory synapses whereas neuroligins 1 and 3
favor induction of glutamatergic excitatory synapses (Song et al.,
1999; Varoqueaux et al., 2004). Results from in vitro studies demon-
strated that neuroligin–neurexin interactions promote synapse forma-
tion in hippocampal neurons (Chih et al., 2004; Graf et al., 2004;
Scheiffele et al., 2000). Genetic ablation of speciﬁc isoforms of
neuroligin or neurexin in mice did not cause obvious changes in
synapse number in vivo but did impair synaptic function, leading to
the hypothesis that the predominant in vivo function of neuroligin–
neurexin interactions is to regulate synapse stabilization and activity-
dependent synaptic remodeling (Missler, 2003; Sudhof, 2008;
Varoqueaux et al., 2006). The ﬁnding that chronic inhibition of NMDA
receptors suppresses the synaptogenic activity of neuroligin-1 in vitro
further supports the idea that neuroligins contribute to activity-
dependent modiﬁcation of synapses (Chubykin et al., 2007). More
recently, it has been demonstrated in the Aplysiamodel that neuroligin–
neurexin interactions are critically important in learning-related synaptic
remodeling in vivo (Choi et al., 2011). Collectively, these observations
suggest that neuroligin–neurexin interactions function to stabilize
nascent synapses and modulate activity-dependent synaptic plasticity.
Although NLGN genemutations contribute to b1% of ASD diagnoses,
the association supports the hypothesis that synaptic abnormalities
contribute to ASD (Bourgeron, 2009; Sudhof, 2008). Functional studies
of the NLGN3 R451C and NLGN4 D936X mutations identiﬁed in ASD
subjects reveal defective trafﬁcking and synaptogenic properties of
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the mutant proteins (Chih et al., 2004; Comoletti et al., 2004;
Khosravani et al., 2005). Primary cultures of hippocampal neurons de-
rived from Nlgn3 R471C (the rat substitution that corresponds to the
human R451C missense mutation) exhibit reduced synchrony of spon-
taneous activity patterns relative to neurons cultured from wildtype
rats (Gutierrez et al., 2009). The functional relevance of these pheno-
types to ASD is suggested by reports that Nlgn4 knockout mice display
reduced social interactions and ultrasonic vocalizations as adults
(Jamain et al., 2008), and Nlgn1 overexpressing mice (an alternative
paradigm for achieving the imbalance between neuroligin isoforms
that presumably results when Nlgn3 and/or Nlgn4 are underrepresent-
ed) show signiﬁcant deﬁcits in memory acquisition consistent with a
shift of synaptic balance towards increased excitation and impaired
long-term potentiation (Dahlhaus et al., 2010). In mice, expression of
ASD-linked Nlgn3 and Nlg4mutations is associated with abnormal syn-
aptic function, imbalance between excitatory and inhibitory synapses
and severe autism-like phenotypes (Ey et al., 2011; Jamain et al.,
2008; Tabuchi et al., 2007), and expression of the NLGN3 R451C muta-
tion in the Aplysia motor neuron blocks long-term facilitation (Choi et
al., 2011).Mice null for Shank1 exhibit increased anxiety-related behav-
ior (Hung et al., 2008; Silverman et al., 2011) and communication im-
pairments (Wohr et al., 2011). Collectively, these studies suggest that
altered expression and/or function of these synaptic adhesion proteins
likely contributes to the functional connectivity problems associated
with ASD and perhaps also to the imbalance of excitatory to inhibitory
neurotransmission thought to exist in a signiﬁcant percentage of
ASD subjects, particularly the 30% of ASD subjects with seizures
(Rubenstein andMerzenich, 2003). In support of this hypothesis, recent
functional imaging studies of human brain have demonstrated that ex-
pression of ASD-linked allelic variants of CNTNAP2 is linked to altered
frontal lobar connectivity and white and gray matter reductions in
brain areas normally affected in ASD (Dennis et al., 2011; Scott-Van
Zeeland et al., 2010; Tan et al., 2010). Thus, a risk allele for autism is as-
sociated with signiﬁcant cerebral morphological variation. Interesting-
ly, this association was observed in individuals that did not exhibit
overt symptoms or behavioral abnormalities characteristic of ASD,
suggesting that additional factors interact with these genetic suscepti-
bility factors to determine ASD risk.
2.2. ERK and PI3K pathways in ASD
Data from studies of syndromic ASD also identify the ERK and PI3K
intracellular signaling pathways as a second set of convergent molecu-
lar targets in ASD (Bourgeron, 2009; Levitt and Campbell, 2009). ERK
and PI3K signaling link extracellular signals to mTOR activation, and
the primary membrane receptors that transduce signals through ERK
and PI3K are receptor tyrosine kinases (RTK). ERK (Sweatt, 2004) and
PI3K/mTOR (Jaworski et al., 2005; Kumar et al., 2005; Li et al., 2010) sig-
naling pathways mediate transcriptional and translational mechanisms
of experience-dependent dendritic remodeling and synapse formation
(Li et al., 2010). Disruption of ERK and PI3K signaling either directly or
via altered function of the upstream RTK occurs in several syndromic
disorders with high penetrance of ASD (Levitt and Campbell, 2009).
With respect to the former, mutations in TSC1/TSC2, NF1 or PTEN are
associated with syndromic ASD in the context of tuberous sclerosis,
neuroﬁbromatosis or macrocephaly (Bourgeron, 2009). The protein
products of these genes function as negative effectors of the mTOR-
raptor complex (mTORC); thus, mutations in TSC1/TSC2, NF1 or PTEN
activate mTOR signaling. Mice with conditional Pten knockout in the
cortex and dentate gyrus exhibit reduced social interactions, increased
activity in novel environments, impaired sensorimotor gating coinci-
dent with macrocephaly and alterations in spine density and mor-
phology (Kwon et al., 2006). Administration of rapamycin, a speciﬁc
inhibitor of mTORC1, can reverse aberrant neuronal morphologies and
behavioral defects observed in transgenic mice expressing Pten (Zhou
et al., 2009) or Tsc1/Tsc2 (Ehninger et al., 2008) mutations and reverse
abnormal synaptic functions in adult mouse models of Fragile X (de
Vrij et al., 2008; Dolen et al., 2007) or Rett syndrome (Guy et al., 2007).
An example of an RTK implicated in the genetic etiology of ASD is
the MET RTK (Judson et al., 2011; Levitt and Campbell, 2009). Three
allelic variants of MET, all located in the putative 5′ regulatory region
have been associated with increased ASD risk, and at least one vari-
ant, the functional rs1858830 ‘C’ variant reduces transcriptional efﬁ-
ciency of MET in vitro, consistent with decreased levels of MET
protein expression in the temporal neocortex in ASD post-mortem
cases [reviewed in Judson et al., 2011]. MET is activated by binding
of its endogenous ligand, hepatocyte growth factor (HGF), which in
turn activates signaling through PI3K, ERK and p38 (Trusolino et al.,
2010). In vitro studies demonstrate that MET signaling regulates den-
dritic outgrowth of neocortical and hippocampal pyramidal neurons
and synaptic connectivity between forebrain neurons [reviewed in
Judson et al., 2011], but whether MET signaling mediates similar re-
sponses in vivo has yet to be determined. However, it has recently
been determined thatMetmRNA is expressed in the right cells during
the right time in development to inﬂuence synapse formation in the
developing mouse forebrain, and that kinase-dead, conditional Met
mutant mice exhibit altered dendritic morphology and abnormal
dendritic spine morphology in neocortical pyramidal neurons and en-
hanced local circuitry in restricted layers of the cortex [reviewed in
Judson et al., 2011]. Interestingly the neural circuits impacted in the
Metmutant mouse are those that are important for processing social-
ly relevant auditory and visual cues in the primate (Judson et al.,
2011). Recent structural and functional imaging studies of the
human brain reveal that expression of the cMet allele correlates
with altered structural and functional connectivity in heterozygotic
or homozygotic children and adolescents (Rudie et al., 2012). Inter-
estingly, the MET risk genotype predicted atypical fMRI activation
and deactivation patterns to social stimuli in both neurotypic and
autistic individuals; however, effects were more pronounced in ASD
subjects (Rudie et al., 2012). This is consistent with a multiple hit
model for ASD, in which genetic and environmental risk factors inter-
act to determine ASD risk.
2.3. Intracellular Ca2+ in ASD
While experimental data demonstrate that both the initial forma-
tion of dendrites (Higgins et al., 1997; Lein et al., 1995; Metzger,
2010) and the latter stages of dendritic branching and spine formation
can be driven by activity-independent mechanisms (Frotscher et al.,
2000; Kossel et al., 1997), a principal determinant of neuronal connec-
tivity in the developing brain is electrophysiological activity. Activity
inﬂuences the initial architecture of neural systems and is critical for
reﬁning neural circuits to form functionally integrated networks
(Aamodt and Constantine-Paton, 1999; Cline, 2001; Komuro and
Rakic, 1998; Levitt, 2003; Moody and Bosma, 2005). Activity modu-
lates not only structural aspects of neuronal connectivity, such as den-
dritic branching and spine formation, but also neurochemical aspects
of neuronal connectivity, speciﬁcally neurotransmitter phenotype
(Borodinsky et al., 2004; Spitzer, 2012). The effects of activity on neu-
ronal connectivity are mediated primarily, if not exclusively, by
changes in intracellular Ca2+ levels (Lohmann and Wong, 2005). A
number of candidate risk genes for ASD encode proteins that have a
primary role in generating intracellular Ca2+ signals or are themselves
tightly regulated by local ﬂuctuations in Ca2+ concentrations (Krey
and Dolmetsch, 2007; Pessah and Lein, 2008). These genes encode
Ca2+ ion channels, neurotransmitter receptors and Ca2+-regulated
signaling proteins such as BDNF, CREB, Wnt2, ERK1/2 and PI3K.
Emerging evidence suggests that defective neuronal connectivity
associated with ASD is mediated in part by defects in neuronal Ca2+
signaling (Lohmann, 2009). One illustration of this derives from re-
cent studies of a gain-of-function missense mutation in the L-type
Ca2+ channel CaV1.2 that causes Timothy syndrome, which has a
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60% rate of co-morbidity with autism (Splawski et al., 2004), making
it one of the most penetrant monogenic forms of ASD. Neurons differ-
entiated from induced pluripotent stem cells (iPSC) derived from
Timothy syndrome patients revealed increased Ca2+ oscillations at
rest and persistent Ca2+ signaling upon challenge with a depolarizing
stimulus (Pasca et al., 2011). Additionally, neurons expressing the
Timothy syndrome mutation exhibited increased neuronal complexi-
ty and upregulated expression of genes linked to Ca2+-dependent
regulation of CREB, including CaMK, which is consistent with studies
demonstrating that CaMK signaling through CREB links activity to in-
creased dendritic growth (Wayman et al., 2006). Collectively, these
studies suggest a mechanism underlying the increased local connec-
tivity associated with ASD. A second example is provided by recent
work with CGG trinucleotide expansion repeats within the 5′ non-
coding portion of the Fragile X mental retardation 1 (FMR1) gene.
CGG-repeat expansions in the premutation range (55–200 CGG re-
peats) not only give rise to the neurodegenerative disorder, Fragile
X-associated tremor/ataxia syndrome (FXTAS) but also increase the
risk of developing ASDs early in life (Chonchaiya et al., 2012;
Hagerman et al., 2011). FMR1 expansions with >200 CGG repeats
give rise to Fragile X syndrome (FXS). Collectively, expansion muta-
tions in FMR1 are the most prevalent single gene disorder contribut-
ing ASD risk (Krueger and Bear, 2011; Leehey and Hagerman, 2012).
Hippocampal neurons cultured from a FMR1 premutation knockin
mouse model exhibited impaired dendritic growth and complexity
(Chen et al., 2010) as well as aberrant electrical spiking patterns
and synchronized Ca2+ oscillatory behaviors (Cao et al., 2012b). Sim-
ilar to observations of iPSC-derived neurons expressing the Timothy
syndrome mutation, iPSC-derived FMR1 premutation neurons also
exhibited abnormal Ca2+ transients of higher amplitude and in-
creased frequency and a sustained Ca2+ elevation after glutamate ap-
plication relative to neurons expressing the normal FMR1 allele (Liu
et al., 2012). Such studies clearly establish these Ca2+ signaling mol-
ecules as possible convergence points for genetic variants linked to
ASD risk.
3. Environmental chemicals as risk factors for ASD
Over the last few years, a range of non-genetic factors have been
associated with increased risk for ASD, including pesticides, air pollu-
tion, drugs, paternal age and maternal nutritional, medical or meta-
bolic status (Herbert, 2010; Krakowiak et al., 2012; Landrigan et al.,
2012; McCanlies et al., 2012; Schmidt et al., 2011, 2012; Shelton
et al., 2012; Volk et al., 2011; Zerbo et al., 2012). In this review, we
will focus on environmental chemicals as potential risk factors for
ASD, using organophosphorus pesticides (OPs), polychlorinated
biphenyls (PCBs) and polycyclic aromatic hydrocarbons (PAHs) as
examples. Human exposures to these environmental chemicals are
widespread and, with the possible exception of PCBs (but see
Section 3.2.), generally have increased from the 1980s to the 2000s.
Although their direct involvement in ASD pathophysiology has yet
to be proven, there is experimental evidence that these environmen-
tal chemicals modulate signaling systems implicated in the pathogen-
esis of ASD.
3.1. Organophosphorus pesticides (OPs)
OPs are currently the most commonly utilized pesticides in the
world (Zaim and Jambulingam, 2007). In the United States, about
73 million pounds of OP pesticides were used in 2001 (70% of all
insecticides; Kiely et al., 2004). There is widespread exposure of chil-
dren to these compounds (Adgate et al., 2001; Barr et al., 2004; Curl et
al., 2003; Davis and Ahmed, 1998; Eskenazi et al., 1999; Landrigan et
al., 1999; Lu et al., 2001; Whyatt and Barr, 2001), and OP residues are
detected in the blood and/or urine of nearly all children sampled in
the United States (Barr et al., 2005). OPs are well documented
developmental neurotoxicants. Animal studies show that the devel-
oping nervous system is especially sensitive to the neurotoxic effects
of OPs (Moser et al., 1998; Moser and Padilla, 1998; Pope et al., 1991).
In rats, exposure to OPs during critical stages of brain development
can cause persistent behavioral and cognitive deﬁcits in the absence
of signiﬁcant cholinesterase inhibition (Jett et al., 2001; Levin et al.,
2001, 2002; Slotkin et al., 2001, 2009). Consistent with these experi-
mental animal studies, a number of epidemiological investigations
have reported a positive correlation between chronic exposure to
low-level OPs and behavioral and cognitive problems in children
(Bouchard et al., 2011; Engel et al., 2007, 2011; Eskenazi et al.,
2007; Kofman et al., 2006; Lizardi et al., 2008; Lovasi et al., 2011;
Rauh et al., 2006, 2011; Rohlman et al., 2005). While each individual
study has limitations, including exposure quantiﬁcation (limited to
no data regarding the type of OP, the timing and duration of expo-
sure) and potential confounding factors (e.g., concomitant exposure
to other environmental factors and socioeconomic factors), collec-
tively, results from these studies suggest OP exposure represents a
potential threat to the developing human nervous system.
Several of these epidemiological studies have identiﬁed a link be-
tween OP exposure and outcomes that are relevant to ASD. For exam-
ple, in a study of a longitudinal birth cohort of primarily Latino farm
worker families in California, levels of urinary OP metabolites in
mothers and their children were positively associated with increased
risk of pervasive developmental disorder at 24 months of age and
with attention problems at 5 years of age (Eskenazi et al., 2007;
Marks et al., 2010). In a study of low income communities in New
York City, prenatal exposure to the OP chlorpyrifos, as measured in
umbilical cord plasma, was signiﬁcantly associated with increased
risk of mental delay, attention problems and pervasive developmental
disorder in exposed children at 3 years of age, and with deﬁcits in in-
tellectual development at the age of 7 (Rauh et al., 2006, 2011). Addi-
tional epidemiological evidence hinting at a link between OP
exposures and ASD risk is the reports that ASD susceptibility is
inﬂuenced by functional polymorphisms in PON1, which encodes the
major enzyme involved in OP detoxiﬁcation, paraoxonase (PON-1)
(D'Amelio et al., 2005; Gaita et al., 2010; Pasca et al., 2006). However,
PON-1 not only hydrolyzes organophosphate esters but also plays an
important role in lipid metabolism (Androutsopoulos et al., 2011),
which has been suggested to be altered in ASD (Szatmari et al.,
2007). Whether PON1 polymorphisms inﬂuence ASD risk via effects
on OP detoxiﬁcation, lipid metabolism or both remains an unan-
swered question. However, the potential for PON1 polymorphisms to
inﬂuence OP neurotoxicity is suggested by the Mount Sinai Children's
Environmental Health study of a multiethnic population in New York
City. In this study, prenatal urinary and blood levels of OP metabolites
were negatively associated with cognitive development at 12 and
24 months of age in the Black/Hispanic group, with effects being
more pronounced at 12 months in children of mothers who carried
the PON1 Q192R polymorphism associated with a slower rate of OP
detoxiﬁcation (Engel et al., 2011). Interestingly, the association be-
tween OP metabolite levels and cognitive development was reversed
in the White group. The signiﬁcance of these differences across ethnic
groups is difﬁcult to assess since the PON1 polymorphisms were not
studied in theWhite group, and the authors did not consider environ-
mental parameters known to affect PON1 status (Androutsopoulos
et al., 2011).
A biological mechanism supporting an association between devel-
opmental exposures to OPs and ASD has yet to be described. It seems
unlikely that OPs cause ASD per se but rather OPs interact with ASD
susceptibility genes to drive neurodevelopmental systems over the
threshold for ASD expression. Inherent imbalances in synaptic
connectivity in children at risk for ASDs (see Section 2) are likely to
provide the biological substrate for enhanced susceptibility to envi-
ronmental triggers that interfere with synaptic connectivity. OPs
have been shown to interfere with normal patterns of neuronal
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connectivity in experimentalmodels. The OP chlorpyrifos decreases ax-
onal but enhances dendritic growth in cultured neurons (Howard et al.,
2005; Yang et al., 2008) and disrupts axonal growth in developing
zebraﬁsh (Jacobson et al., 2010; Yang et al., 2011). Developmental expo-
sure to chlorpyrifos also alters levels of presynapticmarkers of choliner-
gic neurons, e.g., choline acetyltransferase and hemicholinium-3
binding in rats (Dam et al., 1999; Slotkin et al., 2001), suggesting that
OPs interfere with synapse formation in the intact mammalian brain.
Consistent with these observations of altered neuronal connectivity in
experimentalmodels of OP developmental neurotoxicity, a recentmag-
netic resonance imaging (MRI) study of children between the ages of 6
and 11 reported a signiﬁcant association between structural anomalies
of cortical surface features and prenatal exposure to the OP chlorpyrifos
as quantiﬁed in umbilical cord blood (Rauh et al., 2012). The mecha-
nisms by which OPs interfere with neuronal connectivity remain
speculative; however, experimental evidence suggests that OPs may
modulate the same signaling pathways linked to genetic risk factors
for ASD.
One intriguing possibility is that OPs alter normal synaptogenesis
by interfering with neuroligin–neurexin interactions. This hypothesis
derives from observations that chlorpyrifos and its oxon metabolite
inhibit axon outgrowth in primary cultured neurons by interfering
with the morphogenic activity of acetylcholinesterase (AChE) inde-
pendent of effects on the enzyme's hydrolytic activity (Yang et al.,
2008). Interestingly, the morphogenic domain of AChE shares striking
structural and functional homology with the extracellular domain of
neuroligins (Dean and Dresbach, 2006; Graf et al., 2004). Deletion
mutation studies show that synaptogenic activities of neuroligin are
mediated by speciﬁc sequences within its AChE-homologous extra-
cellular domain, which are necessary and sufﬁcient when expressed
in HEK293 cells to induce presynaptic differentiation in axons
(Scheiffele et al., 2000). Conversely, transfection with neuroligin re-
stores neurite outgrowth in PC12 cells whose expression of AChE is
suppressed by antisense treatment (Grifman et al., 1998), conﬁrming
functional redundancy. Considered in aggregate, these observations
suggest the possibility that OPs interact with the esterase domain of
neuroligins to interfere with their synaptogenic activity. If true, then
OPs would be predicted to exacerbate ASD-related NLGN mutations,
which decrease expression of neuroligin at the cell surface (Sudhof,
2008), by further decreasing the availability of functional neuroligin
molecules. This hypothesis has yet to be tested experimentally. An al-
ternative mechanism by which OPs may disrupt neuroligin–neurexin
interactions is suggested by a recent microarray study in which
repeated postnatal exposure to chlorpyrifos-oxon was reported to
signiﬁcantly decrease the expression of Nlgn2 in the cerebellum of
mice (Cole et al., 2011). These results were conﬁrmed by quantitative
PCR, and were related to PON1 activity.
OPs have also been shown to alter the expression and/or function
of various proteins that inﬂuence neuronal connectivity via ERK and
PI3K signaling, speciﬁcally reelin and neurotrophins. Reelin and
neurotrophins have both been implicated in genetic ASD etiologies.
Reelin, which is encoded by the RELN gene, is an extracellular prote-
ase that activates PI3K signaling via binding to the very low-density
lipoprotein (VLDL) receptor and the apolipoprotein E receptor 2
(APOE-R2) (Forster et al., 2010). Reelin promotes maturation of den-
drites and dendritic spines and modulates synaptic function; these ef-
fects are mediated by both its protease activity and signaling through
PI3K (Forster et al., 2010; Quattrocchi et al., 2002). Variants of the
RELN gene that express≥12 repeats of a polymorphic GGC repeat
found in the 5′-UTR of the RELN gene immediately adjacent to the
AUG initiator codon blunt RELN gene expression by 25–50% both
in vitro (Persico et al., 2006) and in vivo (Lugli et al., 2003). Long
GGC repeat variants have been associated with ASD in North Ameri-
can and Slovakian populations (Kelemenova et al., 2010; Persico et
al., 2006; Serajee et al., 2006; Skaar et al., 2005; Zhang et al., 2002);
however, these ﬁndings were not replicated in studies conducted in
Italy, France, England, Germany or the Chinese Han population
(Bonora et al., 2003; Devlin et al., 2004; He et al., 2011; Krebs et al.,
2002; Li et al., 2004). The identiﬁcation of geographic differences
between these epidemiological studies suggests the possibility
that an environmental factor interacts with the long RELN allelic
variants to confer susceptibility to ASD (Pardo and Eberhart,
2007; Persico and Bourgeron, 2006). It has been proposed that
OPs may be one such factor (Persico and Bourgeron, 2006). OPs
have been shown to decrease Reln mRNA expression in the devel-
oping rat forebrain (Betancourt et al., 2006), and OPs potently in-
hibit the proteolytic activity of reelin (Quattrocchi et al., 2002).
Considered in light of data indicating greater household use of
OPs in North America compared to Europe during the period corre-
sponding to the infancy and early childhood of the study popula-
tion (Persico and Bourgeron, 2006), these observations suggest
that exposure to OPs during critical periods of neurodevelopment
pushes individuals carrying the long RELN allelic variants below a
threshold of reelin expression required for the development of
normal neuronal connectivity.
Neurotrophins, which include brain-derived neurotrophic factor
(BDNF) and neurotrophin 3 (NT-3), are soluble trophic factors that
play a critical role in determining both local and long-range neuronal
connectivity (Chapleau et al., 2009; da Silva and Wang, 2011;
McAllister, 2000). Developmental exposure to OPs has been shown
to decrease expression of BDNF and other neurotrophins in the
brain of rodents and chicken (Betancourt et al., 2006; Betancourt et
al., 2007; Pomeroy-Black et al., 2007; Slotkin et al., 2008). This effect
could theoretically contribute to the reduced long-range connectivity
associated with ASD and potentially also to the enhanced local
connectivity associated with ASD. Neurotrophins elicit complex re-
sponses from central neurons and a single neurotrophin can have
opposing effects on dendritic growth (McAllister et al., 1997). In
slice cultures of the visual cortex, BDNF stimulates dendritic growth
of layer 4 neurons whereas NT-3 inhibits their growth; in contrast,
BDNF is inhibitory and NT-3 stimulatory for neurons in layer 6
(McAllister et al., 1997). This effect was observed with endogenous
or exogenous neurotrophins and required neural activity (McAllister
et al., 1996). BDNF modulates dendritic growth and plasticity by acti-
vating PI3K/mTOR signaling downstream of binding to the tyrosine
kinase (Trk) receptors, which are members of the RTK family of trans-
membrane receptors (Gong et al., 2006; Jaworski et al., 2005; Kumar
et al., 2005; Takei et al., 2004). This suggests the possibility that OPs
interact with ASD susceptibility genes at the level of the PI3K/
mTOR/PTEN signaling pathway. These signaling molecules mediate
BDNF effects on neuronal connectivity and as discussed above
(Section 2), they have been implicated in several forms of syndromic
ASD (Levitt and Campbell, 2009). Decreased neurotrophin expression
caused by developmental OP exposure may also push individuals
with inherited deﬁciencies in neurotrophin expression, such as Rett
syndrome patients, closer to the threshold for ASD. Rett syndrome,
which has a high penetrance of ASD, is associated with mutations in
the transcription factor MeCP2 (Amir et al., 1999). Bdnf mRNA ex-
pression is regulated by MeCP2 (Chen et al., 2003; Martinowich
et al., 2003), and Bdnf transcript expression is diminished in mice
nullizygous for Mecp2 (Chang et al., 2006) or expressing Rett-
associated Mecp2 mutations (Larimore et al., 2009). Bdnf overex-
pression prevents dendritic atrophy caused by Rett-associated
Mecp2 mutations in hippocampal neurons (Larimore et al., 2009) and
rescues MeCP2 null mice from behavioral and electrophysiological def-
icits (Chang et al., 2006). BdnfmRNA expression is lower in brain sam-
ples from Rett subjects (Abuhatzira et al., 2007); however, protein
expression is not changed (Lappalainen et al., 1996; Leblond et al.,
2012; Riikonen, 2003; Riikonen and Vanhala, 1999; Vanhala et al.,
1998). The relevance of the latter is not clear since it is well established
that local translation of BdnfmRNA in dendrites in response to activity is
critical for synaptic plasticity (Chapleau et al., 2009).
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OPs may also interact with heritable deﬁciencies in Ca2+ signaling
to confer increased ASD risk. Calcium-dependent activator protein for
secretion 2 (CAPS2) enhances the release of BDNF and NT-3 from
vesicles in parallel ﬁbers in the developing cerebellum and mutations
in the gene that encodes CAPS2 has been associated with increased
ASD susceptibility (Sadakata and Furuichi, 2009). Mice that are
nullizygous for Casp2 exhibit impaired BDNF release and they express
autism-like behaviors, including decreased social interaction, hyper-
activity in the home cage but decreased exploratory behavior and/or
increased anxiety in a novel environment (Sadakata and Furuichi,
2009). While there is considerable debate regarding the validity of
animal models of ASD (Halladay et al., 2009), it would be interesting
nonetheless to determine whether OP-induced reductions in
neurotrophin levels exacerbate these behavioral phenotypes in the
Casp2 null mice. Additional Ca2+-regulated proteins that are modu-
lated by OPs include cAMP response element binding protein
(CREB) and Wnt. OPs signiﬁcantly increase phosphorylation of CREB
in primary cultures of hippocampal and cortical neurons with EC50
values in the femtomolar to picomolar range (Schuh et al., 2002).
CREB is a pivotal signaling molecule in transcriptional mechanisms
of activity-dependent growth of dendrites, dendritic spine formation
and synaptic plasticity (Wayman et al., 2008). Its relevance to ASD
is suggested by the report of aberrant CREB activity in neurons differ-
entiated from iPSC of Timothy syndrome patients (Pasca et al., 2011).
Wnt is another Ca2+-dependent signaling molecule implicated
in transcriptional mechanisms of activity-dependent dendritic
arborization and synaptogenesis (Salinas and Zou, 2008; Wayman
et al., 2006) that has been associated with increased ASD risk (De
Ferrari and Moon, 2006; Krey and Dolmetsch, 2007; Okerlund and
Cheyette, 2011). Toxicogenomic studies of mice exposed gesta-
tionally to chlorpyrifos or diazinon identiﬁed signiﬁcant changes in
the expression of the Wnt signaling pathway and these changes oc-
curred independent of AChE inhibition (Moreira et al., 2010; Slotkin
et al., 2008).
Collectively, these observations suggest multiple mechanisms by
which OPs might interact with ASD risk genes to exacerbate defects
in neuronal connectivity. Individuals with heritable deﬁciencies in
neuroligin–neurexin–SHANK signaling, reelin or BDNF signaling
through the PI3K/mTOR pathway or Ca2+-dependent signaling mole-
cules that link neural activity or experience to changes in neuronal
connectivity may be particularly vulnerable to the adverse effects of
OPs. In addition to testing these hypotheses, it will also be important
to determine whether interactions are unique to a given subset of OPs
or can be generalized across all OPs, particularly since much of the
data currently available regarding the developmental neurotoxicity
has focused on chlorpyrifos with signiﬁcantly fewer data available
on other commonly used OPs.
3.2. Polychlorinated biphenyls (PCBs)
PCBs are a group of organic compounds classiﬁed according to
their molecular structure as dioxin-like or non-dioxin-like (NDL).
Congeners with >1 ortho-substituted chlorine are typically NDL,
while only twelve PCB congeners with b2 ortho-chlorine substituents
are dioxin-like in their toxicity (Safe, 1993). Industrial PCB mixtures
were used mostly as coolants and lubricants from the 1930s until
1977, when their production was banned in the United States. How-
ever, PCBs are still in use in the United States as dielectric ﬂuids in
transformers and capacitors. While environmental and human PCB
levels dropped signiﬁcantly between 1970 and 1995, recent studies
of temporal trends show no or only a slight decrease in environmen-
tal PCB levels since the mid-1990s (Hornbuckle et al., 2006), which is
thought to be due to secondary PCB sources. For example, PCBs were
heavily used in large metropolitan areas and are now released into
the environment from building materials and other sites of PCB use
(Jamshidi et al., 2007). Furthermore, PCB contamination is not static.
For example, mass ﬂux studies demonstrate that large quantities of
PCBs are deposited and volatilized every year from Lake Michigan
(Hornbuckle et al., 2006). These studies suggest that there is still con-
siderable risk for human exposures to PCBs, which is corroborated by
studies demonstrating the persistence of high residue levels in foods,
particularly ﬁsh, and in human tissue samples (DeCaprio et al., 2005;
Humphrey et al., 2000; Park et al., 2007).
Critical reviews of epidemiological studies have concluded that
the weight of evidence indicates a negative association between de-
velopmental exposure to environmental PCBs andmeasures of neuro-
psychological function in infancy or childhood (Carpenter, 2006;
Korrick and Sagiv, 2008; Schantz et al., 2003; Winneke, 2011). Com-
bined in utero and lactational PCB exposure correlates with decreased
scores on IQ tests, impaired learning and memory, psychomotor difﬁ-
culties, and attentional deﬁcits. While discrepancies between studies
with respect to the spectrum and persistence of adverse neuro-
behavioral outcomes, the confound of co-exposures and differences
in congener proﬁles that comprise the exposure raise questions
about the causative role of PCBs in human developmental neurotoxic-
ity (Winneke, 2011), experimental ﬁndings in animal models conﬁrm
that developmental PCB exposure causes deﬁcits in learning and
memory (Hany et al., 1999; Sable et al., 2006; Schantz et al., 1989;
Widholm et al., 2001; Yang et al., 2009) and sensorimotor functions
(Nguon et al., 2005; Powers et al., 2006; Roegge et al., 2004). While
it is posited that developmental exposure to PCBs contributes to in-
creased ASD risk (Grandjean and Landrigan, 2006; Landrigan, 2010;
Landrigan et al., 2012), there are as yet no epidemiological data to
support this hypothesis.
Recent studies of the cellular and molecular mechanisms by which
PCBs interfere with neurodevelopment reveal that NDL PCBs
modulate Ca2+-dependent signaling pathways that are implicated
in ASD. Ca2+ imaging studies of cultured rat hippocampal neurons
(Wayman et al., 2012a) revealed that acute exposure to the NDL con-
gener PCB 95 promotes the same bursting type of Ca2+ activity as was
reported in neurons expressing gene mutations that confer ASD sus-
ceptibility, speciﬁcally the gain-of-function missense mutation in
the L-type Ca2+ channel CaV1.2 that causes Timothy syndrome
(Pasca et al., 2011) and the FMR1 premutation (Cao et al., 2012b;
Liu et al., 2012) (see Section 2). Consistent with the established role
of intracellular Ca2+ signaling in activity-dependent dendritic growth
(Lohmann and Wong, 2005) and with the morphogenic analyses of
neurons expressing either the Timothy syndrome mutation or FMR1
premutation, PCB 95 also triggered increased dendritic complexity
in cultured rat hippocampal neurons, and these effects were signiﬁ-
cantly different from untreated controls at picomolar to nanomolar
PCB concentrations (Wayman et al., 2012a, 2012b). PCB 95 effects
on dendritic arborizationwere blocked by pharmacological antagonism
or siRNA knockdown of the Ca2+/calmodulin kinase-I (CaMKI)–CREB–
Wnt signaling pathway (Wayman et al., 2012a), which is the
Ca2+-dependent signaling pathway previously shown to link activity
to dendritic growth in cultured hippocampal neurons (Wayman et al.,
2006). Genes encoding these same Ca2+-dependent signaling mole-
cules are implicated as ASD susceptibility genes (Krey and Dolmetsch,
2007; Pessah and Lein, 2008), and the proteins encoded by these
genes are upregulated in iPSC-derived neurons fromTimothy syndrome
patients (Pasca et al., 2011) (see Section 2). Thus, this Ca2+-dependent
signaling pathway represents a potential convergent molecular target
for both NDL PCBs and ASD risk genes that interfere with a ﬁnal com-
mon path of activity-dependent dendritic arborization and plasticity.
The human health relevance of this hypothesis is supported by ob-
servations that developmental PCB exposure modulates dendritic
growth in vivo. Gestational and lactational exposure to Aroclor 1254
(A1254) in the maternal diet signiﬁcantly increased dendritic arbori-
zation of pyramidal neurons in the CA1 region of the hippocampus of
weanling rats (Wayman et al., 2012b). In a separate study of
experience-dependent dendritic growth, gestational and lactational
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exposure to Aroclor 1254 promoted dendritic growth in cerebellar
Purkinje cells and neocortical pyramidal neurons among untrained
animals but attenuated or reversed experience-dependent dendritic
growth among Morris water maze-trained littermates (Yang et al.,
2009). A1254 is comprised predominantly of NDL PCB congeners
(Kostyniak et al., 2005), and consistent with the hypothesis that
these congeners are primarily responsible for the effects of A1254
on neuronal connectivity, developmental exposure to PCB 95 in the
maternal diet signiﬁcantly increased dendritic growth of CA1 pyrami-
dal neurons in the hippocampus of untrained weanling rats at the low
(0.1–1.0 mg/kg/d in the maternal diet) but not at the highest dose
tested (6.0 mg/kg/d in the maternal diet) (Wayman et al., 2012b).
Developmental exposures to A1254 and PCB 95 also cause perfor-
mance deﬁcits in the Morris water maze task in weanling rats (Yang
et al., 2009) and alter activity levels and behavior in the radial arm
maze in adult rats (Schantz et al., 1997). Perinatal exposure to a mix-
ture of the NDL PCB 47 and the dioxin-like PCB 77 has recently been
reported to alter social behaviors in rats (Jolous-Jamshidi et al.,
2010). Another example of PCB interference with neuronal connectiv-
ity in the developing brain of signiﬁcant relevance to ASD is the ﬁnd-
ing that developmental exposure to PCB 95 interferes with the
topographic organization of the primary auditory cortex and creates
an imbalance between excitation and inhibition in the auditory
cortex of weanling rats (Kenet et al., 2007). If similar effects occur
in children, it seems plausible that these could contribute to deﬁcits
in communication and social interactions that are core to ASD diagno-
ses and symptomology.
Additional mechanistic studies establish that the effects of NDL
PCBs on dendritic arborization and Ca2+-dependent signaling path-
ways that regulate neuronal connectivity are mediated by ryanodine
receptor (RyR)-dependent mechanisms. While several mechanisms
have been shown to contribute to PCB effects on intracellular
Ca2+ (Kodavanti, 2005; Mariussen and Fonnum, 2006), the most
sensitive is RyR sensitization (Wong et al., 1997a, 1997b; Wong and
Pessah, 1996). RyRs are microsomal Ca2+ channels that are broadly
expressed throughout the mammalian brain and associate with cyto-
solic, endoplasmic reticulum (ER)-anchored and ER luminal proteins
to form local Ca2+ release units (CRUs). These CRUs regulate Ca2+
release from the ER and modify gating responses and signal gain of
plasma membrane ion channels, including the NMDA receptor,
thereby determining the amplitude and spatial and temporal ﬂuctua-
tion of intracellular Ca2+ during cell activation (Pessah et al., 2010).
Nanomolar concentrations of PCB congeners with multiple ortho
substituents interact with CRUs to dramatically sensitize their acti-
vation by nanomolar Ca2+ and attenuate their inhibition by high
micromolar to millimolar Ca2+ and Mg2+ (Wong et al., 1997a;
Wong and Pessah, 1996), thus stabilizing the RyR in its full open
conformation (Samso et al., 2009). A stringent structure–activity
relationship was identiﬁed for this effect with the NDL congener
PCB 95 being the most potent and efﬁcacious congener identiﬁed
to date (Pessah et al., 2010). Blocking RyR activity using either
pharmacological approach or siRNA knockdown of RyR prevents
PCB 95 enhancement of both synchronized Ca2+ oscillations
(Wayman et al., 2012a) and dendritic growth (Wayman et al.,
2012b), and blocks activation of the CaMK–CREB–Wnt2 signaling
pathway (Wayman et al., 2012a).
So, are studies with PCB 95 relevant to human exposures and to
ASD? The answer is an unqualiﬁed yes. There is increasing evidence
that NDL PCBs predominate in environmental samples (Hwang et
al., 2006; Kostyniak et al., 2005), human blood (DeCaprio et al.,
2005; Stewart et al., 1999) and brain samples from weanling rats
developmentally exposed to A1254 (Yang et al., 2009). An intriguing
example from human studies is the recent ﬁnding that PCB 95, the
most active PCB congener in dysregulating ASD-relevant Ca2+-
dependent signaling pathways (Pessah et al., 2010; Wayman et al.,
2012a) is found in signiﬁcantly higher levels in postmortem brains
of children with a syndromic form of autism, but not idiopathic au-
tism, as compared to neurotypical controls (Mitchell et al., 2012).
The samples with detectable PCB 95 levels were almost exclusively
those with maternal 15q11–q13 duplication (Dup15q) or deletion
in Prader–Willi syndrome. When sorted by birth year, Dup15q
samples represented ﬁve of six samples with detectable PCB 95
levels and a known genetic cause of ASD born after the 1976 PCB
ban. Dup15q was the strongest predictor of PCB 95 exposure across
age, gender, or year of birth. Dup15q brain samples had lower levels
of repetitive DNA methylation measured by LINE-1 pyrosequencing,
but methylation levels were confounded by year of birth. These
results suggest a novel paradigm by which speciﬁc NDL persistent
organic pollutants (POPs) may predispose to genetic CNVs of
15q11–q13.
NDL PCB congeners with the highest activity towards RyRs, in-
cluding PCB 95, collectively represent 40–50% of total PCBs currently
found in environmental and biotic samples, and their net effects are
likely to be additive (Pessah et al., 2006). However, even low levels
of exposure to these PCB congeners might adversely inﬂuence neuro-
nal connectivity in the developing brain of genetically susceptible
individuals, such as those with heritable deﬁciencies in Ca2+ signal-
ing. In addition to ASD risk genes that encode molecules that inﬂu-
ence the CaMK–CREB–Wnt2 signaling pathway that converges on
dendritic arborization (see Section 2), mutations in RYR genes suggest
another genetic susceptibility that might amplify the adverse effects
of RyR-active PCBs on neuronal connectivity. RYR mutations have
been linked to environmentally-triggered disorders in humans
including malignant hyperthermia (Gronert et al., 2004), cardiac
arrhythmias (Wehrens et al., 2005), and sudden death (Laitinen et
al., 2004). Recent studies demonstrate that speciﬁc RYR mutations
confer sex- and gene dose-dependent susceptibility to pharmacolog-
ical (halogenated anesthetic) and environmental (heat) stressors that
trigger malignant hyperthermia and muscle damage in otherwise
asymptomatic individuals (Barrientos et al., 2012; Yuen et al.,
2012). Importantly, PCB 95 is signiﬁcantly more potent and efﬁca-
cious in disrupting cation regulation of mutant R615C-RYR1 com-
pared to wild type RyR1 (Ta and Pessah, 2007). While a previous
single nucleotide polymorphism study concluded that there was no
evidence of an association between RYR3 and autism in a Japanese
population (Tochigi et al., 2008), a joint association test of results
from a genome wide association study identiﬁed RyR2 as an ASD can-
didate gene by using sex as an additional risk factor (Lu and Cantor,
2012).
Considered in aggregate, these observations provide important
new clues about the possible role of RyRs in contributing to heritable
and environmentally triggered neurodevelopmental deﬁcits, and
identify PCBs, and in particular NDL PCBs with high RyR activity,
as candidate environmental risk factors in ASD. It also suggests that
other non-coplanar POPs that sensitize RyR, such as PBDEs (Kim et
al., 2011) and triclosan (Cherednichenko et al., in press), should be
evaluated as potential environmental risk factors for ASD by deter-
mining whether they, like NDL PCBs, also interfere with late
neurodevelopmental processes that deﬁne neuronal connectivity.
3.3. Polyaromatic hydrocarbons (PAHs)
Polycyclic aromatic hydrocarbons (PAHs) are a class of ubiquitous
environmental pollutants generated by the incomplete combustion of
organic chemicals. Major sources of human exposure to PAHs, such as
benzo(α)pyrene (B(α)P), are motor vehicle exhaust, contaminated
food and water, tobacco smoke and wood smoke. Research on the
toxicity of B(α)P and other PAHs has focused primarily on their role
as cancer risk factors. However, several recent epidemiological stud-
ies have turned attention to the potential for these environmental
chemicals to inﬂuence ASD risk.
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A prospective cohort study of nonsmoking African-American and
Dominican mothers and children in New York City evaluated prenatal
exposure to airborne PAHs monitored during pregnancy by personal
air sampling and the measurement of DNA adducts speciﬁc to B(α)
P. Child behavior was assessed using the Child Behavior Checklist.
At age 3, prenatal exposure to PAHs was not associated with psycho-
motor development index or behavioral problems; however, high
prenatal exposure to PAHs (upper quartile) was associated with
lower mental development index (Perera et al., 2006). At age 6,
high prenatal PAH exposure was positively associated with symptoms
of Anxious/Depressed and Attention Problems (Perera et al., 2012). A
parallel study of Caucasian mothers and children in Krakow, Poland
similarly reported a positive association between prenatal exposure
to airborne PAHs (as determined by 48 hour personal air monitoring
as well as a maternal blood sample and/or cord blood sample) and ad-
verse effects on cognitive behavior in children at 5 years of age
(Edwards et al., 2010). A recent study examining the association be-
tween trafﬁc-related air pollution and ASD diagnoses identiﬁed a pos-
itive association between residential proximity to freeways during
the third trimester of pregnancy and autism (Volk et al., 2011). This
study did not, however, ﬁnd an association between ASD diagnoses
and living near other major roads, suggesting that other confounders
not included in the study may have contributed to the association
noted in the study participants living near freeways. However, be-
cause speciﬁc contaminants were not identiﬁed in air samples from
the residences of study participants, it is possible that the different
outcomes reﬂect the differences in contaminant proﬁles or burdens
between sampling sites. PAHs are a major constituent of motor vehi-
cle exhaust, thus these studies are not inconsistent with the proposal
that PAHs contribute to ASD risk.
Rodent studies of perinatal exposure to B(α)P have reported a va-
riety of effects on neuronal connectivity in vitro and in vivo, such as:
(1) downregulation of cortical and hippocampal ionotropic glutamate
receptor subunit expression and altered cortical electrophysiology
(Brown et al., 2007); (2) impaired long-term potentiation in the hip-
pocampus and deﬁcits in behavioral learning (Wormley et al., 2004);
and (3) impaired NMDA-mediated somatosensory cortex neuronal
activity (McCallister et al., 2008). Emerging evidence suggests that
B(α)P may interact with the rs1858830 ‘C’ allele of the RTK MET to
amplify ASD risk. As discussed in Section 2, the C-MET allele has
been identiﬁed as a candidate autism gene and it is associated with
decreased expression of MET and altered neuronal connectivity in
cortical regions. Mouse pups exposed to B(α)P via oral gavage of
dams on embryonic days 14 through 17 resulted in a signiﬁcant
downregulation of both transcriptional and translational products of
Met in the cortex during the ﬁrst two weeks after birth, which corre-
sponds to the time of peak synaptogenesis in the developing mouse
brain (Sheng et al., 2010). In addition, prenatal B(α)P exposure re-
duced the binding of the transcription factor SP1 to DNA targets
(Hood et al., 2000). Similarly, the C allele of MET is associated with
reduced SP1 binding to DNA consensus sequences (Marshall et al.,
2008). These observations suggest the testable hypothesis that B(α)
P converges on the MET signaling pathway to amplify the dys-
regulated neuronal connectivity associated with expression of the
C-MET allele. Positive results would suggest MET signaling as a con-
vergent molecular target to develop as a screen for environmental
chemicals that interact with genetic susceptibility factors to increase
ASD risk.
4. Conclusions
A signiﬁcant contribution from environmental factors in deter-
mining ASD risk is consistent with both the rapid increase in ASD
incidence and the clinical heterogeneity that is the hallmark of
this neurodevelopmental disorder. However, this phenotypic hetero-
geneity together with the complex multigenic etiologies of ASD
signiﬁcantly increases the challenge of identifying speciﬁc environ-
mental factors that confer increased risk for ASD. We suggest that re-
sources be focused on identifying mechanisms by which
environmental factors interact with genetic factors to inﬂuence ad-
verse neurodevelopmental outcomes of relevance to ASD in experi-
mental models. Such mechanistic insights can then be used to
develop rapid throughput screens for potential environmental risk
factors, which in turn will inform and focus epidemiological studies.
While a number of mechanisms have been proposed to explain
gene×environment interactions that inﬂuence ASD risk (Herbert,
2010), one fundamental way in which heritable genetic vulnerabil-
ities can amplify the adverse effects triggered by environmental
exposures is if both factors (genes×environment) converge to
dysregulate the same neurotransmitter and/or signaling systems at
critical times during development (Pessah and Lein, 2008). Several
signaling pathways have emerged from genetic studies as convergent
molecular mechanisms or targets in ASD, and data is already accumu-
lating of environmental chemicals that potentially interact with
those signaling pathways. These emerging data suggest a biological
framework not only for studying mechanisms by which speciﬁc envi-
ronmental and genetic factors interact to inﬂuence adverse neuro-
developmental outcomes of relevance to ASD, but also for setting up
screening of environmental chemicals to identify potential ASD risk
factors. While we have focused on structural components of neuronal
connectivity in this review, this biological framework can be readily
adapted to studies of other parameters of neuronal connectivity that
are regulated by these signaling pathways, e.g., Ca2+-dependent reg-
ulation of neurotransmitter speciﬁcation (Borodinsky et al., 2004;
Spitzer, 2012).
The success of this strategy is predicated on choosing appropriate
model systems. While a number of transgenic animals (mice, and
more recently, rats), expressing ASD-linked genetic mutations have
been or are being developed, the costs associated with the use of
these models limit their utility for early mechanistic and screening
approaches (Lein et al., 2005). Such models do, however, serve an im-
portant role in conﬁrming putative gene×environment interactions
identiﬁed in simpler systems. But for initial mechanistic and screen-
ing studies, we propose the use of in vitro models (such as primary
neuronal cell cultures) or simple systems-based models (such as
Caenorhabditis elegans or Danio Rerio) that recapitulate the late stages
of neurodevelopment thought to be disrupted in ASD (see Section 2).
Ongoing research demonstrates that such models can be adapted for
rapid throughput screening acrossmultiple culturewells simultaneously
using, for example, high content imaging systems to analyze dendritic
morphology and synaptic density (Harrill et al., 2011), microelectrode
arrays tomeasure network activity as ameasure of functional connectiv-
ity (Johnstone et al., 2010; Robinette et al., 2011), or the FLIPR® to assess
spontaneous calcium oscillations (Cao et al., 2012a).
Another consideration is the role of cross-talk between signaling
systems that inﬂuence neuronal connectivity. For example, Ca2+
plays a signiﬁcant role in both the neuroligin–neurexin–SHANK and
the ERK/PI3K molecular pathways. Neuroligins contain an EF-hand
metal binding motif and neuroligin–neurexin binding requires the
binding of Ca2+ to neurexin (Nguyen and Sudhof, 1997). Additional-
ly, Ca2+ regulates the activational status of both ERK and PI3K. Ca2+
signaling also regulates the expression of the MET RTK (Dai et al.,
2012), and changes in the levels of intracellular Ca2+ derived from ei-
ther external or internal sources inﬂuence MET activation via tyrosine
phosphorylation (Gandino et al., 1990, 1991; Naldini et al., 1991).
Furthermore, dendritic growth and branching triggered by binding
of HGF to the MET RTK is mediated by Ca2+-dependent mechanisms
(Tyndall et al., 2007). Conversely, SHANK regulates the synaptic clus-
tering of CaV1.3 L-type calcium channels, and interfering with the
binding of SHANK to these ion channels attenuates CaV1.3 channel
activation of CREB (Zhang et al., 2005). It is perhaps not surprising
that there is signiﬁcant crosstalk between these molecular pathways,
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and thus risk factors that primarily target one molecular pathway
may have indirect effects on the other molecular pathways thereby
potentially amplifying or attenuating effects on neuronal connectivi-
ty. Thus the net outcome of environmental exposures on neuronal
connectivity will reﬂect the balance between these signaling path-
ways, which are likely to be differentially impacted depending on
the type, duration and timing of exposure.
Clearly, work is urgently needed to better predict which com-
bination of defective genes and environmental exposures pose the
greatest autism risk. The fact that chemical exposures are more read-
ily controlled than genetic factors to prevent or mitigate the expres-
sion of ASD-related traits coupled with the signiﬁcant toll that ASD
places on children with autism and their families, provides a compel-
ling reason to engage in this endeavor.
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